These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26141958)

  • 1. Meta-Analyses of Statin Therapy for Primary Prevention Do Not Answer Key Questions: An Empirical Appraisal of 5 Years of Statin Meta-Analyses.
    Huded C; Prasad V
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):379-86. PubMed ID: 26141958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benefits and risks for primary prevention with statins in the elderly].
    Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F
    Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
    Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
    BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for the primary prevention of cardiovascular disease in the elderly.
    Lowe RN; Vande Griend JP; Saseen JJ
    Consult Pharm; 2015 Jan; 30(1):20-30. PubMed ID: 25591028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
    Minder CM; Blumenthal RS; Blaha MJ
    Curr Opin Cardiol; 2013 Sep; 28(5):554-60. PubMed ID: 23928920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis.
    de Vries FM; Kolthof J; Postma MJ; Denig P; Hak E
    PLoS One; 2014; 9(11):e111247. PubMed ID: 25372483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H; Brugts J; Ades T
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.
    O'Brien EC; Greiner MA; Xian Y; Fonarow GC; Olson DM; Schwamm LH; Bhatt DL; Smith EE; Maisch L; Hannah D; Lindholm B; Peterson ED; Pencina MJ; Hernandez AF
    Circulation; 2015 Oct; 132(15):1404-13. PubMed ID: 26246175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Wang Z; Zhang Y; Gao M; Wang J; Wang Q; Wang X; Su L; Hou Y
    Pharmacotherapy; 2011 Nov; 31(11):1051-62. PubMed ID: 22026393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial.
    Bonnet F; Bénard A; Poulizac P; Afonso M; Maillard A; Salvo F; Berdaï D; Salles N; Rousselot N; Marchi S; Hayes N; Joseph JP
    Trials; 2020 Apr; 21(1):342. PubMed ID: 32307005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
    Lardizabal JA; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):87-103. PubMed ID: 21257102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.
    Savarese G; Gotto AM; Paolillo S; D'Amore C; Losco T; Musella F; Scala O; Marciano C; Ruggiero D; Marsico F; De Luca G; Trimarco B; Perrone-Filardi P
    J Am Coll Cardiol; 2013 Dec; 62(22):2090-9. PubMed ID: 23954343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
    Kazi DS; Penko JM; Bibbins-Domingo K
    Med Clin North Am; 2017 Jul; 101(4):689-699. PubMed ID: 28577620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance.
    Riaz H; Khan AR; Khan MS; Rehman KA; Alansari SAR; Gheyath B; Raza S; Barakat A; Luni FK; Ahmed H; Krasuski RA
    Am J Cardiol; 2017 Sep; 120(5):774-781. PubMed ID: 28779871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.